Spesana Enters Next Phase Of Growth With Expansion Of Its Business And Commercial Leadership Team

Spesana announced the appointment of John Verniero as Chief Business Officer, Court Veach as Vice President of Sales and Allen Rasoul as Vice President of Strategic Business Development to support Spesana’s next phase of commercial growth.

Verniero brings global experience in the biopharmaceutical and precision medicine industry including at Merck, Amgen and Integra Connect and over the course of his career has led and built finance, sales, marketing, operations, access & reimbursement, business development, strategy, and analytic functions and teams in the U.S., Europe, and Asia and successfully launched numerous small and large molecule biopharmaceutical products, and precision medicine data and technology solutions.  He has also. He has led multiple cross-functional scientific, software, manufacturing, and commercial teams focusing on the delivery of high-quality patient care based on science and data. He received his MBA in finance from Duke University, Fuqua School of Business and his BA in economics and political science from Drew University.

Download Our Top Whitepaper : Building Reliable and Secure Fintech Systems in 2022

“I am thrilled to join Spesana and this talented team of innovators delivering to patients, providers, payors and life science companies a healthcare platform which captures, organizes, and analyzes all the relevant and needed data to ensure that patients get the appropriate treatments they deserve in a timely and efficient manner,” said Verniero. “The Spesana team is bringing newly-harmonized collaboration, decision support and molecular diagnostics results together and making it more widely accessible and actionable.”

“John’s impressive career across critical segments of the global healthcare market is built on a passion for exceptional patient experience and makes him the perfect fit for the Spesana team,” said Spesana CEO Carla Balch. “His leadership in the payor market supports the launch of Spesana’s prior authorization product, which innovates the revenue cycle management of complex healthcare.”

Vice President of Sales Court Veach brings experience with collaborative technologies in healthcare and information technologies particularly aligned with Spesana’s patient referral management tools. He is a 10-year U.S. Army Veteran (officer and enlisted).

Recommended AI News: Flosum Reports Record Growth in 2021, Sets Sights on Enhanced DevSecOps in 2022

“Court engages physicians and health system executives in a collaborative process proven to untangle complex problems,” said Balch. “He is bringing to providers meaningful, revenue-generating opportunities through patient referral management tools and Spesana’s clinical trial portfolio manager. He knows that by providing health systems with true innovation in the hands of talented physicians; patients win.”

Vice President of Strategic Business Development Allen Rasoul was on a path to becoming a physician when he pivoted to the business of healthcare allowing him to combine his passion for patient care with his business sense. Rasoul brings extensive expertise in the biotech space, medical devices, success in new business development, and marketing strategies. Rasoul also adds the power of strategic partnerships with other like-minded companies to benefit the healthcare ecosystem.

“Allen’s deep experience as an entrepreneur brings added discipline to Spesana’s strategic business development,” said Balch. “He has built technology and service companies in healthcare and adds to our seasoned Spesana team. Most of us grew up in the halls of medicine, so we deeply understand the broken processes and super-human efforts that take place in physician offices daily.”

Recommended AI News: Limelight to Acquire Yahoo’s Edgecast, Creating Global Leader in Edge Enabled Software Solutions

[To share your insights with us, please write to sghosh@martechseries.com]